Hemostatic compositions and uses therefor

Inventors

Vournakis, John N. • Finkielsztein, Sergio

Assignees

Marine Polymer Technologies Inc

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-7931637-B2

Patent

Publication Date

2011-04-26

Expiration Date


Abstract

The present invention relates generally to the field of hemostasis, including methods, compositions, and devices that can be employed to achieve hemostasis at an increased rate. More specifically the present invention relates to hemostatic compositions that achieve a hemostatic effect at a distance from the site of application of the composition, and a method for administering such a composition to effectively reduce localized vascular complications associated with treating a breach or puncture in a vein or artery and reduce the time to achieve hemostasis.

Core Innovation

The described invention concerns treatment of vein or artery punctures resulting from cardiac catheterization. It uses a topical composition containing a vasoconstrictor together with compression of the punctured vessel. The application site is contiguous with the catheter puncture; the specified distance is [procedural detail omitted for safety]. The vasoconstrictor excludes a poly-̂-1→4 N-acetylglucosamine polymer or derivative.

The supplied description identifies vascular complications, including hematomas, as concerns associated with catheterization punctures and describes the approach as accelerating hemostasis compared with compression and barrier material alone. It also presents the treatment as an alternative to invasive closure devices. The background section itself is not included in the supplied content, so no further background problem is described here.

Claims Coverage

The supplied relevant claims identify two independent claims: one covers treatment of a vein or artery puncture after cardiac catheterization, and the other specifically covers a femoral artery puncture. Each combines a topical vasoconstrictor composition with compression; the specified application distance is [procedural detail omitted for safety].

Treatment of a vein or artery puncture after cardiac catheterization

The independent claim describes a method using a topical composition with an effective amount of one or more vasoconstrictors, excluding a poly-̂-1→4 N-acetylglucosamine polymer or derivative, together with compression of the punctured vein or artery. The specified application distance is [procedural detail omitted for safety].

Treatment of a femoral artery puncture after cardiac catheterization

The independent claim describes a method using a topical composition with an effective amount of one or more vasoconstrictors, excluding a poly-̂-1→4 N-acetylglucosamine polymer or derivative, together with compression of the punctured femoral artery. The specified application distance is [procedural detail omitted for safety].

The two independent claims cover treatment of catheterization-related vessel punctures, with the second directed specifically to the femoral artery. Both describe the combination of a topical vasoconstrictor composition and compression.

Stated Advantages

Accelerates hemostasis compared with compression and barrier material alone.

Reduces hematomas and other localized vascular complications.

Avoids invasive closure devices.

Documented Applications

Treatment of vein or artery punctures resulting from cardiac catheterization.

Treatment of a femoral artery puncture resulting from cardiac catheterization.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.